Influence of Passive Permeability on Apparent P-glycoprotein Kinetics
- 1 January 2000
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 17 (12), 1456-1460
- https://doi.org/10.1023/a:1007692622216
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification systemInternational Journal of Pharmaceutics, 2000
- Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.Journal of Pharmaceutical Sciences, 1999
- Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites.1999
- Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical ApproachPharmaceutical Research, 1999
- Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoproteinBiochemical Pharmacology, 1998
- Human P-Glycoprotein Exhibits Reduced Affinity for Substrates during a Catalytic Transition StateBiochemistry, 1998
- Efficiency of P‐glycoprotein–Mediated Exclusion of Rhodamine Dyes from Multidrug‐Resistant Cells is Determined by their Passive Transmembrane Movement RateEuropean Journal of Biochemistry, 1997
- Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.Proceedings of the National Academy of Sciences, 1994
- Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.1994
- Drug Absorption Limited by P-Glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell LayersPharmaceutical Research, 1993